All Stories

CytoDyn must face investor lawsuit alleging misleading claims in COVID, HIV drug debacle

Investors sued CytoDyn and former executives for allegedly misleading shareholders on the status of its potential treatment for HIV and COVID-19.

Jun 27, 2025 - 17:45
 0
CytoDyn must face investor lawsuit alleging misleading claims in COVID, HIV drug debacle
Investors sued CytoDyn and former executives for allegedly misleading shareholders on the status of its potential treatment for HIV and COVID-19.
Read More

Tags:

Previous Article

FDA removes CAR-T access barriers in move set to boost cancer immunotherapy uptake

Next Article

FDA takes major step to ease access to CAR-T therapy

Related Posts

Fierce Biotech Layoff Tracker 2025: Vertex sheds 125 staffers; Genentech lays off 143 workers

Fierce Biotech Layoff Tracker 2025: Vertex sheds 125 st...

Jun 11, 2025  0

Sanofi inks $470M Vigil buyout, brushing off rivals’ failures to join Novartis in Alzheimer’s race

Sanofi inks $470M Vigil buyout, brushing off rivals’ fa...

May 22, 2025  0

Court extends block on HHS RIF after Trump's Supreme Court appeal

Court extends block on HHS RIF after Trump's Supreme Co...

May 23, 2025  0